2007
2006
2005
2004
2003
2002
2001
2000
1999
1998
1997
1996
1995
1994

    

 


Company Abstracts  ::  2000
2000 Presentation Abstracts   2000 Publications Abstracts

PHARMACOKINETICS AND POTENCY OF TOLERAGENIC COMPOUNDS: SCREENING OF CANDIDATE COMPOUNDS FOR THE TREATMENT OF ANTIPHOSPHOLIPID SYNDROME
Eric M. Smith, et al.
Presented at
The 26th Annual Conference of the La Jolla Immunologists
La Jolla, California
October 24-25, 2000
USE OF SINGLE POINT MUTATIONS IN DOMAIN 1 OF b2GPI TO DETERMINE FINE ANTIGENIC SPECIFICITY OF ANTIPHOSPHOLIPID AUTOANTIBODIES.
G. Michael Iverson, et al.
Presented at
The 9th International Symposium on Antiphospholipid Antibodies
Tours, France
September 12-16, 2000

Also presented at the
26th Annual Conference of the La Jolla Immunologists
October 24-25, 2000
La Jolla, California, USA

TOLERANCE ACTIVITY AND PHARMACOKINETICS OF MULTIVALENT b2GP1 DOMAIN ONE CONJUGATES IN AN IMMUNIZED ANIMAL MODEL.
Michael J. Branks, et al.
Presented at
The 9th International Symposium on Antiphospholipid Antibodies
Tours, France
September 12-16, 2000


A CONVENIENT SYNTHESIS OF N-(TERT-BUTYLOXYCARBONYL) AMINOOXY ETHERS.
David S. Jones, et al.
Published in
Tetrahedron Letters
41 (2000) 1531-1533


Terms of Use & Privacy Policy
Copyright © 2008, La Jolla Pharmaceutical Company